Skip to main content Back to Top


Simethicone Oral Liquid

Products Affected - Description

    • Simethicone oral suspension, GlaxoSmithKline, 20 mg/0.3 mL, 30 mL bottle, NDC 00043-6243-01 - discontinued
    • Simethicone oral suspension, Major, 20 mg/0.3 mL, 30 mL bottle, NDC 00904-5894-30 - discontinued
    • Simethicone oral suspension, Perrigo, 20 mg/0.3 mL, 30 mL bottle, NDC 00113-0882-10 - discontinued

Reason for the Shortage

    • Geri-Care has simethicone oral liquid available.
    • GSK Consumer Healthcare discontinued Baby Gas-X simethicone oral solution.
    • Major discontinued simethicone oral liquid.
    • Perrigo discontinued simethicone oral liquid due to low demand for the product.
    • Rugby has simethicone oral liquid available.

Available Products

    • Simethicone oral suspension, Geri-Care, 20 mg/0.3 mL, 30 mL bottle, NDC 57896-0798-01
    • Simethicone oral suspension, Rugby Laboratories, 20 mg/0.3 mL, 30 mL bottle, NDC 00536-1303-75


Updated June 11, 2021 by Leslie Jensen, PharmD, Drug Information Specialist. Created February 3, 2020 by Rachael Freeman, PharmD, BCPS. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.